BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11796614)

  • 1. Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.
    Erdogan S; Fagan PK; Talay SR; Rohde M; Ferrieri P; Flores AE; Guzmán CA; Walker MJ; Chhatwal GS
    Infect Immun; 2002 Feb; 70(2):803-11. PubMed ID: 11796614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice.
    Gravekamp C; Rosner B; Madoff LC
    Infect Immun; 1998 Sep; 66(9):4347-54. PubMed ID: 9712787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity.
    Michel JL; Madoff LC; Kling DE; Kasper DL; Ausubel FM
    Infect Immun; 1991 Jun; 59(6):2023-8. PubMed ID: 1674738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protective surface protein from type V group B streptococci shares N-terminal sequence homology with the alpha C protein.
    Lachenauer CS; Madoff LC
    Infect Immun; 1996 Oct; 64(10):4255-60. PubMed ID: 8926097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group B streptococcal surface proteins as targets for protective antibodies: identification of two novel proteins in strains of serotype V.
    Areschoug T; Stålhammar-Carlemalm M; Larsson C; Lindahl G
    Infect Immun; 1999 Dec; 67(12):6350-7. PubMed ID: 10569749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections.
    Stålhammar-Carlemalm M; Stenberg L; Lindahl G
    J Exp Med; 1993 Jun; 177(6):1593-603. PubMed ID: 8496678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes.
    Gravekamp C; Horensky DS; Michel JL; Madoff LC
    Infect Immun; 1996 Sep; 64(9):3576-83. PubMed ID: 8751902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse-protective antibodies against the Ibc proteins of group B streptococci.
    Bevanger L; Naess AI
    Acta Pathol Microbiol Immunol Scand B; 1985 Apr; 93(2):121-4. PubMed ID: 3893032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tandem repeat deletion in the alpha C protein of group B streptococcus is recA independent.
    Puopolo KM; Hollingshead SK; Carey VJ; Madoff LC
    Infect Immun; 2001 Aug; 69(8):5037-45. PubMed ID: 11447184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein.
    Madoff LC; Michel JL; Gong EW; Kling DE; Kasper DL
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4131-6. PubMed ID: 8633028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotype IX, a Proposed New Streptococcus agalactiae Serotype.
    Slotved HC; Kong F; Lambertsen L; Sauer S; Gilbert GL
    J Clin Microbiol; 2007 Sep; 45(9):2929-36. PubMed ID: 17634306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of group B streptococcal Sip protein, which elicits cross-protective immunity.
    Brodeur BR; Boyer M; Charlebois I; Hamel J; Couture F; Rioux CR; Martin D
    Infect Immun; 2000 Oct; 68(10):5610-8. PubMed ID: 10992461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha.
    Larsson C; Stålhammar-Carlemalm M; Lindahl G
    Infect Immun; 1996 Sep; 64(9):3518-23. PubMed ID: 8751893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic diversity in the alpha C protein of group B streptococci.
    Madoff LC; Hori S; Michel JL; Baker CJ; Kasper DL
    Infect Immun; 1991 Aug; 59(8):2638-44. PubMed ID: 1855984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins.
    Stâlhammar-Carlemalm M; Areschoug T; Larsson C; Lindahl G
    J Infect Dis; 2000 Jul; 182(1):142-9. PubMed ID: 10882591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The putative R1 protein of Streptococcus agalactiae as serotype marker and target of protective antibodies.
    Moyo SR; Maeland JA; Lyng RV
    APMIS; 2001 Dec; 109(12):842-8. PubMed ID: 11846725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-localized protein antigens of group B streptococci.
    Ferrieri P
    Rev Infect Dis; 1988; 10 Suppl 2():S363-6. PubMed ID: 3055205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties and distribution of the putative R3 protein of Streptococcus agalactiae.
    Kvam AI; Bevanger L; Maeland JA
    APMIS; 1999 Sep; 107(9):869-74. PubMed ID: 10519324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to the R4 protein antigen of group B streptococci and its relationship to other streptococcal R4 proteins.
    Fasola EL; Flores AE; Ferrieri P
    Clin Diagn Lab Immunol; 1996 May; 3(3):321-5. PubMed ID: 8705677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe.
    Moyo SR; Maeland JA; Bergh K
    J Med Microbiol; 2002 Jul; 51(7):595-662. PubMed ID: 12132777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.